Provides unlimited primary and specialty care for employers via CloudClinics and telehealth with no out-of-pocket costs for members.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Rezilient Health provides unlimited primary and specialty care for employers through CloudClinics and telehealth, offering a direct care model that eliminates out-of-pocket costs for members. The company focuses on improving health outcomes and reducing overall healthcare costs for businesses by enabling same-day appointments and integrated care delivery.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Rezilient Heath Management Team
Investors
Acorn Pacific
David Karandish
GOVO Venture Partners
Jeremy Friese
Jim McKelvey
Mark and Robyn Jones
The Council
Rezilient Heath Valuations & Financials
View real-time NPM data on Rezilient Heath stock including daily Rezilient Heath stock price estimates, valuation history, and historical share price information. Access Rezilient Heath financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Rezilient Heath pricing across six independent market signals. Looking for private company due diligence data sources on Rezilient Heath? Get in touch to learn more.
Similar Companies
like Rezilient Heath
Sunbird Bio
Healthcare & Life Sciences
Develops blood-based diagnostic tests that detect protein properties for earlier, more accurate diagnosis of neurological disorders and cancer.
Cadence Neuroscience
Healthcare & Life Sciences
Provides digital tools that quantify brain function and cognitive health for more precise clinical assessment and tracking.
Glimpse
Healthcare & Life Sciences
Delivers X-ray scanning tools for internal defect detection and factory-grade assurance workflows.
Stramsen Biotech
Healthcare & Life Sciences
Develops plant-based medicines targeting various diseases, aiming to offer safer and more effective treatments with reduced side effect
Supira Medical
Healthcare & Life Sciences
Develops devices that provide temporary heart support during procedures, improving blood flow and enabling safer, more effective treatment.
Genvax Technologies
Healthcare & Life Sciences
Developing that delivers customizable animal vaccines through a self‑amplifying RNA platform tailored to evolving disease variants.
Renasant Bio
Healthcare & Life Sciences
Develops compounds that target genetic kidney disease pathways to halt progression with innovative oral therapies.
OpenLoop
Healthcare & Life Sciences
Supports virtual care delivery by offering integrated operational platforms and service management tools.
Zus Health
Healthcare & Life Sciences
Healthcare data platform that streamlines patient information sharing between providers to enable better coordinated care delivery.
FAQ
We have answers
Rezilient Heath stock does not trade on public stock exchanges. Rezilient Heath stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Rezilient Heath stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Rezilient Heath Stock does not trade on public stock exchanges. In order to sell Rezilient Heath shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Rezilient Heath does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Rezilient Heath share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Rezilient Heath stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Rezilient Heath stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Rezilient Heath stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Rezilient Heath is a private company and has not had an IPO. There is currently no Rezilient Heath IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Rezilient Heath IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
